Global Patent Index - EP 1311293 A2

EP 1311293 A2 20030521 - COMBINATIONS OF SSRI AND ESTROGENIC AGENTS

Title (en)

COMBINATIONS OF SSRI AND ESTROGENIC AGENTS

Title (de)

KOMBINATIONEN AUS SSRI UND ÖSTROGENMITTELN

Title (fr)

COMBINAISONS D'INHIBITEURS SPECIFIQUES DE RECAPTAGE DE LA SEROTONINE ET D'AGENTS OESTROGENIQUES

Publication

EP 1311293 A2 20030521 (EN)

Application

EP 01952310 A 20010629

Priority

  • US 0120738 W 20010629
  • US 21640800 P 20000706

Abstract (en)

[origin: WO0203975A2] This invention comprises methods of treating depression, anxiety, generalized anxiety disorder (GAD), hot flush, post partum depression, premenstrual syndrome, obesity, obsessive compulsive disorder, post-traumatic stress disorder, social phobia, disruptive behavior disorders, impulse control disorders, borderline personality disorder, chronic fatigue disorder, premature ejaculation, pain, attention deficit disorders, with and without hyperactivity, Gilles de la Tourette syndrome, bulimia nervosa, or Shy Drager Syndrome comprising administration of a selective serotonin reuptake inhibitor and compound of the formula I or II: wherein Z is a moiety selected from the group of: wherein: R1 is selected frm H, OH or the C1-C12 esters or C1-C12 alkyl ehers thereof, benzyloxy, or halogen; or C1-C4 halogenated ethers including trifluoromethyl ether and trichloromethyl ether; R2, R3, R4, R5, and R6 are H, OH or C1-C12 esters or C1-C12 alkyl ethers thereof, halogens, or C1-C4 halogenated ethers, cyano, C1-C6 alkyl, or trifluoromethyl, with the proviso that, when R1 is H, R2 is not OH; Y is as defined; or a pharmaceutically acceptable salt thereof.

IPC 1-7

A61K 45/06; A61K 31/40; A61K 31/445; A61P 25/24

IPC 8 full level

A61K 45/00 (2006.01); A61K 31/40 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/445 (2006.01); A61K 31/454 (2006.01); A61K 31/55 (2006.01); A61K 31/56 (2006.01); A61P 3/04 (2006.01); A61P 15/08 (2006.01); A61P 25/22 (2006.01); A61P 25/24 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07D 209/12 (2006.01)

CPC (source: EP)

A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/405 (2013.01); A61K 31/445 (2013.01); A61K 31/454 (2013.01); A61K 31/55 (2013.01); A61K 31/56 (2013.01); A61P 3/04 (2017.12); A61P 15/08 (2017.12); A61P 15/12 (2017.12); A61P 25/00 (2017.12); A61P 25/22 (2017.12); A61P 25/24 (2017.12); A61P 29/00 (2017.12); A61P 43/00 (2017.12)

C-Set (source: EP)

  1. A61K 31/445 + A61K 31/445
  2. A61K 31/55 + A61K 2300/00
  3. A61K 31/56 + A61K 2300/00
  4. A61K 31/445 + A61K 31/405
  5. A61K 31/445 + A61K 31/135
  6. A61K 31/405 + A61K 31/135
  7. A61K 31/40 + A61K 2300/00
  8. A61K 31/404 + A61K 2300/00
  9. A61K 31/405 + A61K 2300/00
  10. A61K 31/445 + A61K 2300/00
  11. A61K 31/454 + A61K 2300/00

Citation (search report)

See references of WO 0203975A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0203975 A2 20020117; WO 0203975 A3 20020926; AU 7307401 A 20020121; CA 2414938 A1 20020117; CN 1452497 A 20031029; EP 1311293 A2 20030521; EP 1990051 A1 20081112; HK 1052877 A1 20031003; JP 2004502729 A 20040129; MX PA03000170 A 20030527

DOCDB simple family (application)

US 0120738 W 20010629; AU 7307401 A 20010629; CA 2414938 A 20010629; CN 01815252 A 20010629; EP 01952310 A 20010629; EP 08103937 A 20010629; HK 03105156 A 20030716; JP 2002508430 A 20010629; MX PA03000170 A 20010629